G
Grand Pharmaceutical Group Ltd
HKEX:512
Grand Pharmaceutical Group Ltd
HKEX:512
Price:
7.85
HKD
-1.01%
Market Cap:
HK$27.9B
Relative Value
The Relative Value of one Grand Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 7.85 HKD, Grand Pharmaceutical Group Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Grand Pharmaceutical Group Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Grand Pharmaceutical Group Ltd Competitors
Grand Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
G
|
Grand Pharmaceutical Group Ltd
HKEX:512
|
27.5B HKD | 2.3 | 13.2 | 14.1 | 14.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD | 14.8 | 46.7 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.4B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.3B GBP | 5.2 | 32 | 15.3 | 22.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.9B CHF | 5.2 | 21 | 13 | 16.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 4 | 12.2 | 8.9 | 10.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD | 2.5 | 20 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
